Close
Enter your
text here
Monthly Archives :

June 2025

Cystic Fibrosis: Screening, Diagnosis and Therapy
 Cystic Fibrosis: Screening, Diagnosis and Therapy 1024 522 Pam Georgiana
By: Pam Georgiana
Healthcare, pediatrician and child heart doctor with a patient at hospital, exam on chest with a stethoscope. Black girl smile at pediatric surgeon, talking to a friendly, caring physician she trust.

Since the implementation of universal newborn screening for cystic fibrosis in all states by 2010, the expectation has been that every child with cystic fibrosis would be identified early and benefit from life-extending treatments. The reality, however, is more complex. “Because of the complexities of the genetic causes of cystic fibrosis and significant variations in…

ACMG Issues Primer on Regulation of Laboratory-Developed Tests
 ACMG Issues Primer on Regulation of Laboratory-Developed Tests 1024 683 Lauren Dembeck
By: Lauren Dembeck

The new statement, co-authored by a Nationwide Children’s laboratory geneticist, outlines how lab-developed tests are regulated and offers patient-centered recommendations for modernizing oversight. Laboratory-developed tests (LDTs) are validated testing protocols developed by certified clinical laboratories for patient care and play an essential role in diagnosing and guiding treatment for many conditions that affect pediatric patients.…

Forging the Future of Sarcoma Care and Research
 Forging the Future of Sarcoma Care and Research 150 150 Nationwide Children's
By: Nationwide Children's

Precision Medicine for Children With Sarcoma At age 7, Will was diagnosed with an osteosarcoma after breaking his leg while visiting his grandmother in Pennsylvania. Scans of the injury revealed that Will’s broken leg was likely caused by a tumor. Hundreds of miles from home and overwhelmed by their son’s crushing cancer diagnosis, Will’s parents…

Featured Researcher – Ryan Roberts, MD, PhD
 Featured Researcher – Ryan Roberts, MD, PhD 150 150 Gina Vitale, PTA
By: Gina Vitale, PTA

Ryan D. Roberts, MD, PhD, is a physician in the Division of Hematology and Oncology at Nationwide Children’s Hospital and a principal investigator for the Center for Childhood Cancer at the Abigail Wexner Research Institute at Nationwide Children’s Hospital. He is a member of the Translational Therapeutics research program at The James Comprehensive Cancer Center…

Don’t Oversize Your Tissue-Engineered Vascular Grafts: Insights for the Translation of New Surgical Technologies
 Don’t Oversize Your Tissue-Engineered Vascular Grafts: Insights for the Translation of New Surgical Technologies 1024 683 Abbie Miller
By: Abbie Miller

Study shows that adoption of a tissue engineered vascular graft technology currently in clinical trials would require a shift in surgical approach. Tissue engineered vascular grafts (TEVGs) are designed to overcome two important problems associated with synthetic conduits used in surgeries for children with congenital heart disease (CHD): the lack of growth potential and the…

A New Path to Relief: Gastrostomy Tubes Offer Treatment for Children With Autism and Chronic Constipation
 A New Path to Relief: Gastrostomy Tubes Offer Treatment for Children With Autism and Chronic Constipation 1024 680 Pam Georgiana
By: Pam Georgiana
Close up color photo of little boy holding hands on his belly

A groundbreaking study reveals how a low-risk intervention dramatically improves quality of life. Children with autism spectrum disorder often struggle with chronic constipation due to behavioral, sensory and dietary challenges. Uncontrolled constipation can cause poor school functioning, eating challenges and sleeping issues. In many cases, due to oral sensory issues, children with autism cannot reliably…

New Trial Aims to Boost Kids’ Immune Systems to Fight Neuroblastoma
 New Trial Aims to Boost Kids’ Immune Systems to Fight Neuroblastoma 1024 558 Lauren Dembeck
By: Lauren Dembeck

A new cellular therapy approach could improve outcomes and ease the treatment burden for patients and families. Neuroblastoma is rare, with only 700 to 800 new cases diagnosed in the United States each year, but it is the most common extracranial solid tumor in children. Neuroblastoma typically occurs in children younger than 5 years, with…

How Does Modification of RNA Influence the Development of Pediatrics Dilated Cardiomyopathy?
 How Does Modification of RNA Influence the Development of Pediatrics Dilated Cardiomyopathy? 1024 783 Abbie Miller
By: Abbie Miller

New study shows essential role of RNA methlytransferase-mediated m6A modification in regulating heart development. Traditional research to understand the origins of congenital heart disease have focused on understanding how genetic mutations may cause heart problems. Now, a team at Nationwide Children’s Hospital is exploring a new way to understand congenital heart disease (CHD). “How the…

Relative Adrenal Insufficiency Observed Among Patients With High-Risk Neuroblastoma During Treatment
 Relative Adrenal Insufficiency Observed Among Patients With High-Risk Neuroblastoma During Treatment 1024 683 Jessica Nye, PhD
By: Jessica Nye, PhD

A subset of patients with high-risk neuroblastoma (NBL) and primary adrenal tumors develop an adrenal insufficiency (AI)-like phenotype during treatment. “We noticed that some of the patients with neuroblastoma had less hypotension when we added hydrocortisone while they were getting dinutuximab therapy. So, we said, I wonder if that has anything to do with the…

Treating Severe Pediatric Kidney Disease with Simultaneous Bilateral Native Nephrectomy
 Treating Severe Pediatric Kidney Disease with Simultaneous Bilateral Native Nephrectomy 480 320 Pam Georgiana
By: Pam Georgiana

A 15-year review of indications, approaches and outcomes. A recent study published in Pediatric Transplantation and led by Christina B. Ching, MD, pediatric urologist in the Department of Pediatric Urology at Nationwide Children’s Hospital, offers valuable insights into a very rare clinical procedure: simultaneous bilateral native nephrectomies, or the removal of both kidneys at the…